Press Releases from Proteros biostructures GmbH (16 total)
PROTEROS ANNOUNCES SUCCESSFUL CLOSE OF FINANCING ROUND
Largest-ever Financing allows for Expansion of Drug Discovery Capabilities
MARTINSRIED, GERMANY (August 6th, 2012) – Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed…
Proteros and Eisai Co., Ltd enter into Integrated Lead Discovery Collaboration
Martinsried (Germany), April 16, 2012. Proteros biostructures GmbH today announced that the company has entered into a research collaboration with Eisai Co., Ltd (Japan) to…
Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific O …
Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company…
Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global …
Martinsried Jan 09, 2012. Janssen Research & Development, a division of Janssen Pharmaceutica NV (“Janssen”) and Proteros biostructures GmbH (“Proteros”) today announced they have entered…
Proteros has relocated to a tailor-made facility in Martinsried
Martinsried, October 24th 2011. Proteros biostructures GmbH is further extending its business capacities by moving into a new building in Munich-Martinsried, one of the leading…
Almirall enters into Integrated Discovery Agreement with Proteros
Barcelona, September 22, 2011. Almirall, S.A. and Proteros biostructures GmbH today announced they have entered into a research collaboration to identify small molecule inhibitors against…
Rigel and Proteros renew X-ray protein crystallography collaboration
Martinsried, Germany, July 12, 2011. Proteros Biostructures GmbH (“Proteros”) announced today that it has renewed its agreement with Rigel Pharmaceuticals, Inc. (Rigel) to provide structural…
Proteros and Institut Pasteur Korea establish discovery services collaboration i …
Martinsried, Germany, May 24, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under…
Proteros and Hutchison MediPharma enter into long-term research collaboration ag …
Martinsried, Germany, May 17, 2011. Proteros Biostructures GmbH (“Proteros”) announced today that they entered into a substantial research collaboration agreement with Hutchison MediPharma Limited (“HMP”),…
Proteros announces New Supervisory Board Appointments: Chairman David Lemus and …
Martinsried, Germany, May 10th, 2011. Proteros biostructures GmbH (Proteros) announced today a new supervisory board composition that is aligned with its growth and development objectives…
Nimbus Discovery and Proteros enter into multi-target X-ray protein crystallogra …
Martinsried, Germany, March 23, 2011. Proteros Biostructures GmbH (“Proteros”) announced today that it has entered into a strategic collaboration with Nimbus Discovery, LLC (“Nimbus”) to…
Proteros and CHDI Foundation, Inc. establish discovery services collaboration to …
Martinsried, Germany, March 16, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with CHDI Foundation, Inc. (CHDI), under…
Proteros and University of Cincinnati, Drug Discovery Center establish collabora …
Martinsried, Germany, March 09, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into an agreement with University of Cincinnati, Drug Discovery Center…
Dr. Axel Ullrich, Director at the Max Planck Institute of Biochemistry, Martinsr …
Martinsried, Germany, February 21, 2011. Proteros Biostructures GmbH (“Proteros”) and Max Planck Institute (“MPI”) of Biochemistry, Martinsried announced today that Dr. Axel Ullrich has chosen…
Proteros and SUPERGEN enter into an integrated lead discovery agreement
Martinsried, Germany, February 02, 2011. Proteros Biostructures GmbH (Proteros) announced today that it has entered into an agreement with SuperGen Inc., under which Proteros will…
Proteros enters into a research agreement for structure based lead generation
Martinsried, Germany, September 27th, 2010. Proteros biostructures GmbH (Proteros) announced today that it has entered into an agreement with Johnson & Johnson Pharmaceutical Research &…
Go To Page:
